The World Health Organization defines a rare disease as having a prevalence of 65 or less per 100,000 individuals. It recognizes some 5,500 rare diseases, the majority being of genetic origin and often life-threatening. Medical research has yielded significant drug development for the treatment of rare diseases, increasing life expectancy and improving quality of life. However, […]
An article outlining the implications of a single-payer universal pharmacare system was the most-read story on BenefitsCanada.com this week. Here are the top five human resources, benefits, pension and investmnet stories of the past week: 1. Sounding Board: What plan sponsors should know about pharmacare 2. Meet the 2024 Workplace Benefits Awards judges 3. Mental-health claims by Canadians up […]
An article on the federal government’s national pharmacare bill receiving approval in the House of Commons was the most-read story on BenefitsCanada.com this week. Here are the top five human resources, benefits, pension and investment stories of the past week: 1. Pharmacare bill passes in House of Commons, heads to Senate 2. 32% of Canadian SMEs facing […]
An article on legal challenges filed against the federal government’s hybrid work mandate for public service employees was the most-read story on BenefitsCanada.com this week. Here are the top five human resources, benefits, pension and investment stories of the past week: 1. Unions representing federal public service workers file legal challenges against hybrid work mandate 2. Expert […]
With employees often struggling to find benefits offerings related to mental-health support or chronic conditions, demand for health-care system navigation services has increased significantly in the past few years. In May 2023, the Bank of Montreal launched a digital mental-health navigation guide, available to employees in both Canada and the U.S., that streamlines access to […]
In its 2024 budget on Tuesday, the federal government announced a new working group dedicated to encouraging increased domestic investments by Canadian institutional investors. Former Bank of Canada governor Stephen Poloz is being tasked to lead an organization that will identify priority investment opportunities in the country for the more than $3 trillion held by […]
An article on the Canadian Life and Health Insurance Association’s priorities for the coming year was the most-read story on BenefitsCanada.com this past week. Here are the top five human resources, benefits, pension and investment stories of the week: 1. CLHIA focusing on improving pharmacare, rare disease drug coverage in 2024 2. Majority of Canadian employers expecting […]
Some pharmacare policy experts are raising concerns about competition and patient access to much-needed medication after Manulife Financial Corp. announced its coverage of certain prescription drugs will only apply at Loblaw Cos. Ltd. pharmacies. The new arrangement, details of which were shared with plan holders earlier this month, affects around 260 medications under the insurance […]
OVERVIEW AGENDA SPEAKERS LOCATION SPONSOR INFORMATION POST EVENT COVERAGE Canadian Leadership Council on Drug Plan Partnerships May 7, 2024 | Vantage Venues, Toronto The value of private drug plans The Canadian Leadership Council on Drug Plan Partnerships has brought together private payer thought leaders to examine the pressing challenges of Canadian private drug plans for […]
A story on how plan sponsors and insurers are considering covering weight-loss drugs as part of a broader push towards more inclusive benefits was the most-read benefits story on BenefitsCanada.com this year. Here are the 10 most popular benefits news stories of the year: 1. How plan sponsors, insurers are considering coverage of weight-loss drugs amid rising […]